Rakovina Therapeutics Inc. | WebDisclosure

Basculer en Français

9904	Companies
199533	Keywords
130386	Articles
106040	Press releases

Headlines Articles Press releases Rakovina Therapeutics Inc.

Home
Companies
Rakovina Therapeutics Inc.

BRIEF

published on 04/02/2025 at 15:36, 10 months 18 days ago

Rakovina Therapeutics Receives Buy Rating from First Berlin Equity Research

Artificial Intelligence DNA Damage Response Rakovina Therapeutics PARP And ATR Biotech Investment
BRIEF

published on 04/02/2025 at 15:36, 10 months 18 days ago

Rakovina Therapeutics reçoit la recommandation d'achat de First Berlin Equity Research

Intelligence Artificielle Rakovina Therapeutics Réponse Aux Dommages À L'ADN PARP Et ATR Investissement En Biotechnologie
PRESS RELEASE

published on 04/02/2025 at 15:31, 10 months 18 days ago

Original-Research: Rakovina Therapeutics Inc. (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research initiates coverage on Rakovina Therapeutics Inc. with a Buy recommendation and CAD 0.40 target price. Rakovina focuses on DNA Damage Response pathways in developing next-gen cancer treatments

First Berlin Equity Research Buy Recommendation Rakovina Therapeutics Inc. DNA Damage Response Pathways CAD 0.40 Target Price

Accesswire

Published on 02/20/2026 at 18:30, 17 minutes ago

Sparta Updates Delay in Filing Annual Financial Statements
Published on 02/20/2026 at 15:45, 3 hours 2 minutes ago

Revolve Announces Closing of Initial US$10 Million Advance on Strategic Financing With Callaway
Published on 02/20/2026 at 14:30, 4 hours 17 minutes ago

Norse Gold Announces Application for Reactivation to TSX-V, Private Placement Financing and Stock Options Grant
Published on 02/20/2026 at 14:08, 4 hours 39 minutes ago

Datavault AI Announces Anticipated Launch of Josh Gibson Stablecoin and Josh Gibson NIL Strategies for Its Forthcoming NIL Exchange
Published on 02/20/2026 at 14:00, 4 hours 47 minutes ago

Nextech3D.ai's Eventdex Platform Powers AI Matchmaking for the SBA's CT Business Matchmaker Event Featuring Government Agencies and Major Prime Contractors

View all ACCESSWIRE

EQS Group

Published on 02/20/2026 at 18:36, 10 minutes ago

EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 15 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 18:23, 23 minutes ago

POS-Transaction in Own Shares
Published on 02/20/2026 at 18:00, 47 minutes ago

Leclanché conclut un accord de financement d’un montant de CHF 16,7 millions pour soutenir ses opérations à court terme
Published on 02/20/2026 at 18:00, 47 minutes ago

Leclanché Secures Financing Arrangement in the amount of CHF 16.7 million to Support Near-Term Operations

Les Echos

Published on 02/20/2026 at 18:00, 47 minutes ago

TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 47 minutes ago

TERACT - Résiliation du contrat de liquidité
Published on 02/20/2026 at 17:35, 1 hour 12 minutes ago

CHIFFRE D'AFFAIRES 2025
Published on 02/20/2026 at 09:28, 9 hours 19 minutes ago

Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 31 janvier 2026
Published on 02/20/2026 at 09:28, 9 hours 19 minutes ago

Statement about the number of shares composing the share capital and the number of voting rights as of January 31, 2026

View all LES ECHOS COMFI WIRE